Wockhardt Stock Rises 9% Following CDSCO Approval of Innovative Antibiotic Zaynich in India
Shares of Wockhardt Ltd. surged by more than 9% on Friday, May 29, following the announcement that the Central Drugs Standard Control…
Wockhardt MD reveals that one in three NHS prescriptions in the UK are for medications produced in India.
Ravi Limaye, Managing Director of Wockhardt, noted that one in three prescriptions within the United Kingdom’s NHS (National Health Service)…